-
Analysis of HIV early infant diagnosis and linkage to care in the Western Cape: a laboratory perspective
-
Analysis of cytomegalovirus UL97 drug resistance mutations in patients receiving Ganciclovir
-
Erythrocyte apoptosis (erythroptosis) and anaemia in chronic HIV-1 infection : relationship with immune activation and viraemia
-
A Study of Genital Human Papillomavirus (HPV) and Evaluation of HPV Testing for Cervical Cancer Screening in Women from the Eastern Cape Province, South Africa
-
Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences
-
Optimisation of the mycobacterial replicon of an E. coli-mycobacterial shuttle vector
-
An investigation into the specific function of the vaccinia virus 13.8 kDa protein encoded by the N1
-
Cellular immune responses to human papillomavirus (HPV) type 16 at the cervix of women with HPV-associated squamous intraepithelial neoplasia
-
Characterization of genotypic and phenotypic properties of transmitted Human Immunodeficiency virus type 1 variants circulating in Mbeya Tanzania
-
Recombinant BCG expressing rotavirus VP6 : construction and evaluation as an anti-rotavirus vaccine
-
A study of host genetic determinants of human papillomavirus (HPV) infection, cervical cancer and herpes simplex virus type-2 (HSV-2) infection
-
Characterisation of HIV superinfection : genetic evolution and adaptive immune responses
-
Prokaryotic Production of Human Immunodeficiency VirusType 1 Subtype C Tat, Nef and Reverse Transcriptase andInvestigation of Antibody Responses to these proteins inHIV-1 Infected Individuals as well as Macaques Vaccinatedwith SAAVI DNA-C/C2 and SAAV
-
Investigation of the use of recombinant BCG, expressing the major capsid protein (LI) of human papillomavirus type 16, as a candidate vaccine for cervical cancer
-
A study of HIV-1 dual infection in a cohort of subtype C infected sex workers : viral evolution and its association with disease progression
-
Recombinant Salmonella enterica serovar Typhimurium vaccine vector expressing green fluorescent protein as a model antigen or human immunodeficiency virus type 1 subtype C Gag
-
An investigation into the Use of Lumpy Skin Disease Virus as a Vaccine Vector for a Potential HIV-1 vaccine
-
Evaluation of the in vivo role of vaccinia virus complement control protein (VCP) following renal ischemia
-
Comparison of HIV-1 specific T cell immunity in the female genital tract and blood of HIV-infected women : impact of in vitro T cell expansion on HIV-specific T cell specificity, maturational status and functional complexity
-
Evolution of HIV-1 subtype C immune responses during acute and chronic HIV infection
-
HIV pathogenesis in the female genital tract during chronic HIV infection : the impact of inflammation, T cell memory differentiation status and homeostatic cytokines on mucosal T cell immunity
-
Adaptive changes in HIV-1 subtype c proteins during early infection and their effect on disease progression
-
An investigation of HIV-1 diversity in Southern Africans, and characterisation of viral populations in recently infected women
-
In vitro characterization of the antiviral activity of Secomet V against vaccinia virus infections
